UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 8, 2024
Accession Number:
0001213900-24-030479
Submission Type:
POS AM
CIK:
0001875091
Company Name:
NeuroSense Therapeutics Ltd.
File Number:
333-273375